Beautiful Virgin Islands

Thursday, Oct 30, 2025

Americans should be warned of coronavirus vaccine side effects, medical experts say

Americans should be warned of coronavirus vaccine side effects, medical experts say

Doctors recommended to federal health officials this week that those who eventually receive the long-awaited coronavirus vaccine should be wary of the side effects - such as body aches and bad headaches - so they will return for the second dose. 
While promising coronavirus vaccine candidates could aid in bringing the pandemic to its heels, doctors recommended to federal health officials this week that those who eventually receive the long-awaited jab should be wary of the side effects - such as body aches and bad headaches - so they will return for the second dose.

Medical experts made such recommendations to advisers with the Centers for Disease Control and Prevention (CDC) this week during an online meeting.

Dr. Sandra Fryhofer of the American Medical Association said on Monday during the meeting with the Advisory Committee on Immunization Practices, a group of medical experts that advise the CDC, that the side effects “won’t be a walk in the park.”

“We really need to make patients aware that this is not going to be a walk in the park,” Fryhofer said, CNBC reported. “They are going to know they had a vaccine. They are probably not going to feel wonderful. But they’ve got to come back for that second dose.”

Two promising coronavirus vaccine candidates, created by the pharmaceutical giant Pfizer and the biotechnology company Moderna, respectively, both require two doses. Participants from both clinical trials have reported side effects after receiving the vaccine candidate, neither of which have been approved by the U.S. Food and Drug Administration at this time. (That said, Pfizer, which was the first to announce the results of its vaccine, recently applied for emergency approval for its vaccine from FDA.)

Earlier this month, one Pfizer vaccine candidate told Fox News that the side effects of the shot were "were a little more severe than I thought."

"I had some side effects," Glenn Deshields, a volunteer from Austin, Texas, told “Fox and Friends” at the time. "Basically, I had a headache and a lot of fatigue, injection site pain ... maybe three to four days.”

“The second one, it was similar but it was much more muted. It wasn't as strong. I think I took some Advil and they basically cleared up,” he said.

As for the Moderna vaccine, CEO Stephane Bancel last week, following news that the company’s candidate was more than 90% effective in late-stage clinical trials, discussed the shot’s side effects during an appearance on Fox Business’ “Mornings with Maria” with host Maria Bartiromo.

"The second dose, you have a bit of side effect locally, a bit of pain, a bit of redness, but it goes away by itself,” he said.

"Some people have a bit of a headache," he continued. "It's nice to note that less than 2% of people get a fever, actually 1.4%, so very, very low."

He said the side effects will self-resolve without taking medication.

“It's actually a good thing in my immunologist always reminds me that having a bit of immune reaction is a good signal that your immune system is working because the vaccine is being activated,” Bancel said at the time.

Meanwhile, during the online meeting with the Advisory Committee on Immunization Practices, Patsy Stinchfield, a nurse practitioner at Children’s Minnesota, suggested that public health officials change the language used when warning the public about side effects. She recommended using the word “response” rather than “adverse reaction,” per CNBC.

“These are immune responses,” said Stinchfield. “And so if you feel something after vaccination, you should expect to feel that. When you do, it’s normal to have some arm soreness or fatigue, some body aches and maybe even a fever. It sounds like in some of these trials, maybe even having to stay home from work.”
Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
UK and Vietnam Sign Landmark Migration Deal to Fast-Track Returns of Irregular Arrivals
UK Drug-Pricing Overhaul Essential for Life-Sciences Ambition, Says GSK Chief
Princesses Beatrice and Eugenie Temporarily Leave the UK Amid Their Parents’ Royal Fallout
UK Weighs Early End to Oil and Gas Windfall Tax as Reeves Seeks Investment Commitments
UK Retail Inflation Slows as Shop Prices Fall for First Time Since Spring
Next Raises Full-Year Profit Guidance After Strong Third-Quarter Performance
Reform UK’s Lee Anderson Admits to 'Gaming' Benefits System While Advocating Crackdown
United States and South Korea Conclude Major Trade Accord Worth $350 Billion
Hurricane Melissa Strikes Cuba After Devastating Jamaica With Record Winds
Vice President Vance to Headline Turning Point USA Campus Event at Ole Miss
U.S. Targets Maritime Narco-Routes While Border Pressure to Mexico Remains Limited
Bill Gates at 70: “I Have a Real Fear of Artificial Intelligence – and Also Regret”
Elon Musk Unveils Grokipedia: An AI-Driven Alternative to Wikipedia
Saudi Arabia Unveils Vision for First-Ever "Sky Stadium" Suspended Over Desert Floor
Amazon Announces 14 000 Corporate Job Cuts as AI Investment Accelerates
UK Shop Prices Fall for First Time Since March, Food Leads the Decline
London Stock Exchange Group ADR (LNSTY) Earns Zacks Rank #1 Upgrade on Rising Earnings Outlook
Soap legend Tony Adams, long-time star of Crossroads, dies at 84
Rachel Reeves Signals Tax Increases Ahead of November Budget Amid £20-50 Billion Fiscal Gap
NatWest Past Gains of 314% Spotlight Opportunity — But Some Key Risks Remain
UK Launches ‘Golden Age’ of Nuclear with £38 Billion Sizewell C Approval
UK Announces £1.08 Billion Budget for Offshore Wind Auction to Boost 2030 Capacity
UK Seeks Steel Alliance with EU and US to Counter China’s Over-Capacity
UK Struggles to Balance China as Both Strategic Threat and Valued Trading Partner
Argentina’s Markets Surge as Milei’s Party Secures Major Win
British Journalist Sami Hamdi Detained by U.S. Authorities After Visa Revocation Amid Israel-Gaza Commentary
King Charles Unveils UK’s First LGBT+ Armed Forces Memorial at National Memorial Arboretum
At ninety-two and re-elected: Paul Biya secures eighth term in Cameroon amid unrest
Racist Incidents Against UK Nurses Surge by 55%
UK Chancellor Rachel Reeves Cites Shared Concerns With Trump Administration as Foundation for Early US-UK Trade Deal
Essentra plc: A Closer Look at a UK ‘Penny Stock’ Opportunity Amid Market Weakness
U.S. and China Near Deal to Avert Rare-Earth Export Controls Ahead of Trump-Xi Summit
Justin time: Justin Herbert Shields Madison Beer with Impressive Reflex at Lakers Game
Russia’s President Putin Declares Burevestnik Nuclear Cruise Missile Ready for Deployment
Giuffre’s Memoir Alleges Maxwell Claimed Sexual Act with Clooney
House Republicans Move to Strip NYC Mayoral Front-Runner Zohran Mamdani of U.S. Citizenship
Record-High Spoiled Ballots Signal Voter Discontent in Ireland’s 2025 Presidential Election
Philippines’ Taal Volcano Erupts Overnight with 2.4 km Ash Plume
Albania’s Virtual AI 'Minister' Diella Set to 'Birth' Eighty-Three Digital Assistants for MPs
Tesla Unveils Vision for Optimus V3 as ‘Biggest Product of All Time’, Including Surgical Capabilities
Francis Ford Coppola Auctions Luxury Watches After Self-Financed Film Flop
Convicted Sex Offender Mistakenly Freed by UK Prison Service Arrested in London
United States and China Begin Constructive Trade Negotiations Ahead of Trump–Xi Summit
U.S. Treasury Sanctions Colombia’s President Gustavo Petro over Drug-Trafficking Allegations
Miss USA Crowns Nebraska’s Audrey Eckert Amid Leadership Overhaul
‘I Am Not Done’: Kamala Harris Signals Possible 2028 White House Run
NBA Faces Integrity Crisis After Mass Arrests in Gambling Scandal
Swift Heist at the Louvre Sees Eight French Crown Jewels Stolen in Under Seven Minutes
U.S. Halts Trade Talks with Canada After Ontario Ad Using Reagan Voice Triggers Diplomatic Fallout
Microsoft AI CEO: ‘We’re making an AI that you can trust your kids to use’ — but can Microsoft rebuild its own trust before fixing the industry’s?
×